Document Detail


Is the Response of Continuous Glucose Monitors to Physiological Changes in Blood Glucose Levels Affected by Sensor Life?
MedLine Citation:
PMID:  22149627     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Abstract Background: None of the studies concerned with the performance of a continuous glucose monitor (CGM) over time has examined the extent to which extended periods of wear affect the responses of both CGM accuracy and lag time to rapid changes in blood glucose levels. Here we propose a novel approach to address these issues. Methods: Eight participants without diabetes were each fitted with two CGMs (Paradigm(®) 722 Real-Time [Medtronic, Northridge, CA]; abdominal and triceps regions) and completed fasted oral glucose challenges (OGCs) on six occasions over a 9-day period, while the CGMs were worn without removal. Arterialized blood samples were collected for comparison with CGM values. Results: There were marked mismatches and lag times between blood glucose and CGM values in response to all OGCs, most notably during the initial rapid increase in glucose levels. Abdominal and triceps CGMs consistently underestimated peak blood glucose by an average of 2.7±0.2 and 2.9±0.2 mM, respectively, and were associated with a peak blood glucose lag of 21.6±1.8 and 18.1±1.6 min, respectively. CGM accuracy did not deteriorate over 9 days of wear in OGCs for either the abdominal or triceps sensor. All participants found the triceps sensor site more comfortable than the abdominal site (P<0.05). Conclusions: The current CGM sensor tested here may be used for extended periods, providing added economic benefits for the wearer. However, the marked inaccuracy and lag time of CGM readings when blood glucose levels change rapidly within the physiological range must be considered for optimal CGM use in glycemic management.
Authors:
Katherine E Iscoe; Raymond J Davey; Paul A Fournier
Related Documents :
18709457 - Mechanisms of disease: the oxidative stress theory of diabetic neuropathy.
8887017 - Long-term effects of eicosapentaenoic acid on diabetic peripheral neuropathy and serum ...
717057 - Myxoedema and thyrotoxicosis: relations between clinical state and concentrations of th...
9041917 - The effect of arterial reconstruction on the natural history of diabetic neuropathy.
2660787 - Modulation of epidermal growth factor-induced cell proliferation and receptor binding b...
21843307 - Validation of an abbreviated adherence measure for young people with type 1 diabetes.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-12-9
Journal Detail:
Title:  Diabetes technology & therapeutics     Volume:  -     ISSN:  1557-8593     ISO Abbreviation:  -     Publication Date:  2011 Dec 
Date Detail:
Created Date:  2011-12-13     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100889084     Medline TA:  Diabetes Technol Ther     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
1 The School of Sport Science, Exercise & Health, The University of Western Australia , Perth, Australia .
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Increased Levels of Serum Granulocyte-Macrophage Colony-Stimulating Factor Is Associated with Activa...
Next Document:  Comparison of Konjac Glucomannan Digestibility and Fermentability with Other Dietary Fibers In Vitro...